From: Public stated preferences and predicted uptake for genome-based colorectal cancer screening
Attribute level | β − coefficient | 95% CI |
---|---|---|
Preparation | Â | Â |
  No preparation | 0.38 (0.02)a | 0.34 to 0.42 |
  Laxatives | −0.03 (0.01)b | −0.06 to -0.01 |
  Enemas | −0.16 (0.01)a | −0.19 to -0.13 |
  Diet plus laxatives# | −0.19 (0.02)a | −0.22 to -0.16 |
Technique | Â | Â |
  Pill | 0.48 (0.02)a | 0.44 to 0.52 |
  Stool | 0.24 (0.02)a | 0.20 to 0.28 |
  Long tube with sedation# | −0.34 (0.02)a | −0.39 to -0.30 |
  Short tube | −0.37 (0.02)a | −0.41 to -0.33 |
Sensitivity | Â | Â |
  100% | 0.36 (0.02)a | 0.32 to 0.39 |
  90% | 0.08 (0.01)a | 0.05 to 0.10 |
  80% | −0.14 (0.01)a | −0.17 to -0.11 |
  70%# | −0.30 (0.02)a | −0.33 to -0.26 |
Specificity | Â | Â |
  100% | 0.15 (0.01)a | 0.12 to 0.17 |
  90% | 0.06 (0.01)a | 0.03 to 0.09 |
  80% | −0.04 (0.01)a | −0.07 to -0.02 |
  70%# | −0.16 (0.02)a | −0.19 to -0.13 |
Complications | Â | Â |
  None | 0.14 (0.02)a | 0.11 to 0.17 |
  1/10.000 | 0.04 (0.01)a | 0.01 to 0.06 |
  10/10.000 | −0.04 (0.01)a | −0.07 to 0.02 |
  100/10.000# | −0.13 (0.02)a | −0.16 to -0.10 |
Frequency | Â | Â |
  Biennial | 0.17 (0.02)a | 0.14 to 0.21 |
  Annual# | 0.03 (0.02) | −0.01 to 0.07 |
  Every 5 years | 0.01 (0.02) | −0.03 to 0.04 |
  Every 10 years | −0.21 (0.02)a | −0.26 to -0.17 |
No screening | −0.29 (0.03)a | −0.36 to -0.23 |